Enovis
Update in progressENOV (NYSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryMedical Devices
Enovis Corporation is a medical technology company that develops clinically differentiated solutions in the United States and abroad. It operates two segments: Prevention and Recovery, and Reconstructive. Prevention and Recovery provides orthopedic braces, hot/cold therapy, bone growth stimulators, vascular therapy, compression garments, electrical pain stimulators, and physical therapy products. Reconstructive develops implants, instrumentation, and enabling technologies for joint replacement, limb reconstruction, and foot/ankle procedures. Products reach customers via distributors, direct sales, and patients. Formerly Colfax Corporation, Enovis was founded in 1995 and is headquartered in Wilmington, Delaware.
Company score
- Sentiment
- -0.16
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.08
- Governance
- -0.03
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.02
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.07
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Company
- MarketNYSE (NYQ)
- LocationUnited States
- CEOMr. Damien McDonald
- Founded1995
- Employees7,802
- Websitewww.enovis.com
Identifiers
- ISINUS1940145022
- FIGIBBG000C5Z443
- LEI635400OP2DYYYMOIYL17
- CUSIP194014502
- CIK0001420800